Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma

Dhruvil Shah, Dariusz Borys, Steve R. Martinez, Chin-Shang Li, Robert M. Tamurian, Richard J Bold, Arta M Monjazeb, Robert J Canter

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

We sought to determine if complete pathological necrosis (pathCR) predicts favorable oncological outcome in soft tissue sarcoma (STS) patients receiving preoperative radiation monotherapy (RT). Patients and Methods: We evaluated 30 patients with primary STS treated with neoadjuvant RT followed by definitive resection, from 2000 to 2010 at our institution. We defined ≥95% tumor necrosis as pathCR. Results: There were 22 STS of the extremities (73%), 7 of the retroperitoneum (23%), and 1 (4%) of the trunk. The median pathological percentage of tumor necrosis was 35% (range 5-100%) with three tumors (10%) demonstrating pathCR. With a median follow-up of 40 months, the 5-year local recurrence-free survival (LRFS), distant recurrence-free survival (DRFS), and overall survival (OS) for the entire cohort were 100%, 61%±11%, and 69%±11%, respectively. Among patients with pathCR, 3-year DRFS was 100% compared to 63±11% in patients without pathCR (p=0.28). Conclusion: Following neoadjuvant RT for STS, pathCR is associated with a clinically but not statistically significant 37% improvement in 3-year DRFS.

Original languageEnglish (US)
Pages (from-to)3911-3916
Number of pages6
JournalAnticancer Research
Volume32
Issue number9
StatePublished - Sep 2012

Fingerprint

Sarcoma
Necrosis
Radiotherapy
Survival
Recurrence
Radiation
Neoplasms
Extremities

Keywords

  • Preoperative radiotherapy
  • Soft tissue sarcoma
  • Survival
  • Tumor necrosis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma. / Shah, Dhruvil; Borys, Dariusz; Martinez, Steve R.; Li, Chin-Shang; Tamurian, Robert M.; Bold, Richard J; Monjazeb, Arta M; Canter, Robert J.

In: Anticancer Research, Vol. 32, No. 9, 09.2012, p. 3911-3916.

Research output: Contribution to journalArticle

@article{56728beda33d40d4ac0a785fd9519eef,
title = "Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma",
abstract = "We sought to determine if complete pathological necrosis (pathCR) predicts favorable oncological outcome in soft tissue sarcoma (STS) patients receiving preoperative radiation monotherapy (RT). Patients and Methods: We evaluated 30 patients with primary STS treated with neoadjuvant RT followed by definitive resection, from 2000 to 2010 at our institution. We defined ≥95{\%} tumor necrosis as pathCR. Results: There were 22 STS of the extremities (73{\%}), 7 of the retroperitoneum (23{\%}), and 1 (4{\%}) of the trunk. The median pathological percentage of tumor necrosis was 35{\%} (range 5-100{\%}) with three tumors (10{\%}) demonstrating pathCR. With a median follow-up of 40 months, the 5-year local recurrence-free survival (LRFS), distant recurrence-free survival (DRFS), and overall survival (OS) for the entire cohort were 100{\%}, 61{\%}±11{\%}, and 69{\%}±11{\%}, respectively. Among patients with pathCR, 3-year DRFS was 100{\%} compared to 63±11{\%} in patients without pathCR (p=0.28). Conclusion: Following neoadjuvant RT for STS, pathCR is associated with a clinically but not statistically significant 37{\%} improvement in 3-year DRFS.",
keywords = "Preoperative radiotherapy, Soft tissue sarcoma, Survival, Tumor necrosis",
author = "Dhruvil Shah and Dariusz Borys and Martinez, {Steve R.} and Chin-Shang Li and Tamurian, {Robert M.} and Bold, {Richard J} and Monjazeb, {Arta M} and Canter, {Robert J}",
year = "2012",
month = "9",
language = "English (US)",
volume = "32",
pages = "3911--3916",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "9",

}

TY - JOUR

T1 - Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma

AU - Shah, Dhruvil

AU - Borys, Dariusz

AU - Martinez, Steve R.

AU - Li, Chin-Shang

AU - Tamurian, Robert M.

AU - Bold, Richard J

AU - Monjazeb, Arta M

AU - Canter, Robert J

PY - 2012/9

Y1 - 2012/9

N2 - We sought to determine if complete pathological necrosis (pathCR) predicts favorable oncological outcome in soft tissue sarcoma (STS) patients receiving preoperative radiation monotherapy (RT). Patients and Methods: We evaluated 30 patients with primary STS treated with neoadjuvant RT followed by definitive resection, from 2000 to 2010 at our institution. We defined ≥95% tumor necrosis as pathCR. Results: There were 22 STS of the extremities (73%), 7 of the retroperitoneum (23%), and 1 (4%) of the trunk. The median pathological percentage of tumor necrosis was 35% (range 5-100%) with three tumors (10%) demonstrating pathCR. With a median follow-up of 40 months, the 5-year local recurrence-free survival (LRFS), distant recurrence-free survival (DRFS), and overall survival (OS) for the entire cohort were 100%, 61%±11%, and 69%±11%, respectively. Among patients with pathCR, 3-year DRFS was 100% compared to 63±11% in patients without pathCR (p=0.28). Conclusion: Following neoadjuvant RT for STS, pathCR is associated with a clinically but not statistically significant 37% improvement in 3-year DRFS.

AB - We sought to determine if complete pathological necrosis (pathCR) predicts favorable oncological outcome in soft tissue sarcoma (STS) patients receiving preoperative radiation monotherapy (RT). Patients and Methods: We evaluated 30 patients with primary STS treated with neoadjuvant RT followed by definitive resection, from 2000 to 2010 at our institution. We defined ≥95% tumor necrosis as pathCR. Results: There were 22 STS of the extremities (73%), 7 of the retroperitoneum (23%), and 1 (4%) of the trunk. The median pathological percentage of tumor necrosis was 35% (range 5-100%) with three tumors (10%) demonstrating pathCR. With a median follow-up of 40 months, the 5-year local recurrence-free survival (LRFS), distant recurrence-free survival (DRFS), and overall survival (OS) for the entire cohort were 100%, 61%±11%, and 69%±11%, respectively. Among patients with pathCR, 3-year DRFS was 100% compared to 63±11% in patients without pathCR (p=0.28). Conclusion: Following neoadjuvant RT for STS, pathCR is associated with a clinically but not statistically significant 37% improvement in 3-year DRFS.

KW - Preoperative radiotherapy

KW - Soft tissue sarcoma

KW - Survival

KW - Tumor necrosis

UR - http://www.scopus.com/inward/record.url?scp=84867020399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867020399&partnerID=8YFLogxK

M3 - Article

C2 - 22993336

AN - SCOPUS:84867020399

VL - 32

SP - 3911

EP - 3916

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 9

ER -